Related Experiment Video

Updated: May 18, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children

Azar Nickavar1, Amir Ebrahim Safarzadeh, Kambiz Sotoudeh

  • 1Aliasghar Children's Hospital, Tehran University of Medical Sciences, Tehran, Iran. anickavar@yahoo.com

Iranian Journal of Kidney Diseases
|September 15, 2012
PubMed

Insights

Mycophenolate mofetil (MMF) effectively maintains remission in children with frequently relapsing nephrotic syndrome (NS). However, MMF showed limited value for children with steroid-resistant NS, offering a safer treatment option for relapsing cases.

Area of Science:

  • Pediatric Nephrology
  • Immunosuppressive Therapy
  • Glomerular Diseases

Background:

  • Idiopathic nephrotic syndrome (NS) in children presents management challenges, particularly frequent relapses or steroid resistance.
  • Long-term corticosteroid and cyclosporine use can lead to adverse effects, necessitating safer treatment alternatives.
  • Evaluating novel immunosuppressants is crucial for improving pediatric NS outcomes.

Purpose of the Study:

  • To assess the safety and efficacy of mycophenolate mofetil (MMF) in pediatric patients with frequently relapsing or steroid-resistant idiopathic NS.
  • To identify patient subgroups that may benefit most from MMF treatment.
  • To compare MMF's effectiveness against existing therapies for difficult-to-treat NS.

Main Methods:

  • Retrospective review of outcomes in children diagnosed with frequently relapsing or steroid-resistant idiopathic NS.
  • Analysis of treatment response rates to mycophenolate mofetil (MMF).
  • Evaluation of patient demographics (age, gender) and their association with MMF response.

Main Results:

  • Mycophenolate mofetil (MMF) demonstrated significant efficacy in 91.6% of children with frequently relapsing NS.
  • Only 8.3% of children with steroid-resistant NS responded to MMF.
  • MMF was well-tolerated, with no significant complications reported across the study cohort.
  • No significant association was found between patient age or gender and MMF response.

Conclusions:

  • Mycophenolate mofetil (MMF) is a safe and effective option for maintaining remission in pediatric patients with frequently relapsing idiopathic NS.
  • MMF has limited therapeutic value in children with steroid-resistant idiopathic NS.
  • MMF offers a promising alternative to traditional immunosuppressants for specific NS patient populations.
Abstract

More Related Videos

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...